Details of the Drug

General Information of Drug (ID: DMYEIOH)

• Drug Name: ARQ-154

Indication

Disease Entry	ICD 11	Status	REF
Plaque psoriasis	EA90.0	Phase 2	[1]

• Drug Type: Small molecular drug
• Cross-matching ID: TTD ID: DH82BG

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Phosphodiesterase 4 (PDE4)	TTV5CGO	NOUNIPROTAC	Inhibitor	[2]

References

• [1] ClinicalTrials.gov (NCT04128007) Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of Arcutis Biotherapeutics.